Page last updated: 2024-10-16

beta-alanine and Hyperpotassemia

beta-alanine has been researched along with Hyperpotassemia in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Dabigatran is a direct thrombin inhibitor indicated for stroke and systemic embolism prevention in patients with non-valvular atrial fibrillation."3.80[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery]. ( Bachellerie, B; Conil, JM; Crognier, L; Fourcade, O; Georges, B; Ruiz, S; Seguin, T, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachellerie, B1
Ruiz, S1
Conil, JM1
Crognier, L1
Seguin, T1
Georges, B1
Fourcade, O1
Zaleski, M1
Dabage, N1
Paixao, R1
Muniz, J1

Other Studies

2 other studies available for beta-alanine and Hyperpotassemia

ArticleYear
[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
    Annales francaises d'anesthesie et de reanimation, 2014, Volume: 33, Issue:1

    Topics: Acute Kidney Injury; Aged, 80 and over; Alzheimer Disease; Antithrombins; Atrial Fibrillation; Benzi

2014
Dabigatran-induced hyperkalemia in a renal transplant recipient: a clinical observation.
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:4

    Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Hyperkalemia; Kidney Transplantatio

2013